Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 6/29/2013 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Malcolm McKay?

Malcolm J. McKay

Vice President, Regulatory Affairs

Celtrix Pharmaceuticals , Inc.

HQ Phone:  (408) 988-2500

Email: m***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Background Information

Employment History

Vice President for Corporate Compliance

InterMune , Inc.


Vice President of Regulatory Affairs

Cell Genesys Inc


Position, Regulatory Affairs and Quality Assurance Areas

Berlex , Inc.


Vice President of Corporate Compliance

TypePad


Vice President, Quality and Regulatory Affairs

BioSpace , Inc


Vice President of Quality and Regulatory Affairs

Calydon , Inc.


Vice President, Regulatory Affairs and Compliance Officer

VIVUS , Inc.


Web References(22 Total References)


Management Team

www.vivus.com [cached]

Malcolm McKay, Ph.D.
Vice President, Regulatory Affairs Dr. McKay has served as the company's Vice President, Regulatory Affairs since June 2010. Dr. McKay has over 25 years of compliance experience covering all aspects of pharmaceutical drug development and commercialization. Prior to joining the company, Dr. McKay was self-employed as a Pharmaceutical Development and Compliance Consultant. Dr. McKay previously served as the Vice President Corporate Compliance with InterMune, Inc. from 2003 to 2007, the Vice President of Quality and Regulatory Affairs with Cell Genesys from 2000 to 2003 and was Vice President Regulatory Affairs with Celtrix Pharmaceuticals from1996 to 2000. Dr. McKay has a PhD in Biochemistry from University of London. Malcolm McKay Ph.D.


Investors - Cell Genesys - Press Release

phx.corporate-ir.net [cached]

Cell Genesys Elects Malcolm McKay Vice President of Quality and Regulatory Affairs
FOSTER CITY, Calif., Nov. 7 /PRNewswire/ -- Cell Genesys, Inc. (Nasdaq: CEGE) today announced that Malcolm J. McKay, Ph.D. has joined the company in the new position of vice president, quality and regulatory affairs. Dr. McKay, who brings over sixteen years of regulatory affairs, quality control and product development experience to Cell Genesys, served most recently as vice president, regulatory affairs at Celtrix Pharmaceuticals, a company which was recently acquired by Insmed, Inc. "We are very pleased to have Malcolm join our management team," stated Stephen A. Sherwin, M.D., chairman and chief executive officer of Cell Genesys. Dr. McKay, 44, previously with Celtrix Pharmaceuticals, has also held various management positions in the regulatory affairs and quality assurance areas with other biotechnology companies including COR Therapeutics, Berlex Biosciences and Triton Biosciences. Dr. McKay holds a Ph.D. in biochemistry from the University of London and a B.S. in biology from the University of Portsmouth in Hampshire, UK. Dr. McKay will be assuming the management of the regulatory affairs function from Dale G. Ando, M.D., vice president of clinical research, who will now focus on the management of the company's rapidly expanding clinical trial programs.


Headlines/Breaking News from San Francisco Business Times - bizjournals.com

sanfrancisco.bizjournals.com [cached]

Foster City-based Cell Genesys Inc. announced that Malcolm McKay has joined the company in the new position of vice president, quality and regulatory affairs.Dr. McKay, who brings over sixteen years of regulatory affairs, quality control and product development experience to Cell Genesys, served most recently as vice president, regulatory affairs at Celtrix Pharmaceuticals, a company which was recently acquired by Insmed Inc.Dr. McKay will be assuming the management of the regulatory affairs function from Dale G. Ando, M.D., vice president of clinical research, who will now focus on the management of the company's rapidly expanding clinical trial programs.


InterMune Announces Executive Appointments and Promotion

biz.yahoo.com [cached]

BRISBANE, Calif., May 13 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN - News) announced today that it has hired Fred J. Schreiber as the Company's new Senior Vice President of Human Resources, and Malcolm McKay, Ph.D., to the newly created position of Vice President of Corporate Compliance.As Vice President of Corporate Compliance, Dr. Malcolm McKay will be responsible for expanding InterMune's Corporate Compliance department and maintaining InterMune's high regulatory standards, including good clinical practices (GCP), current good manufacturing practices (cGMP) and good laboratory practices (GLP).Dr. McKay will report to Dr. Marianne Armstrong, InterMune's Senior Vice President of Global Regulatory Operations and Corporate Compliance. Dr. McKay brings more than 17 years of biopharmaceutical industry experience in the areas of compliance, regulatory, quality assurance and process development to InterMune.Most recently, Dr. McKay was Vice President of Regulatory Affairs at Cell Genesys, where he was responsible for regulatory and quality assurance.Prior to Cell Genesys, Dr. McKay held senior management positions at Celtrix Pharmaceuticals, COR Therapeutics (now Millennium) and Berlex Biosciences.Earlier in his career, he worked at Triton Biosciences and Abbott Laboratories.Dr. McKay holds a Ph.D. in Biochemistry from the University of London and completed his post-doctoral training at the Medical College of Virginia.


InterMune Investor Relations

www.corporate-ir.net [cached]

BRISBANE, Calif., May 13, 2003 /PRNewswire-FirstCall via COMTEX/ -- InterMune, Inc. (Nasdaq: ITMN) announced today that it has hired Fred J. Schreiber as the Company's new Senior Vice President of Human Resources, and Malcolm McKay, Ph.D., to the newly created position of Vice President of Corporate Compliance.As Vice President of Corporate Compliance, Dr. Malcolm McKay will be responsible for expanding InterMune's Corporate Compliance department and maintaining InterMune's high regulatory standards, including good clinical practices (GCP), current good manufacturing practices (cGMP) and good laboratory practices (GLP).Dr. McKay will report to Dr. Marianne Armstrong, InterMune's Senior Vice President of Global Regulatory Operations and Corporate Compliance. Dr. McKay brings more than 17 years of biopharmaceutical industry experience in the areas of compliance, regulatory, quality assurance and process development to InterMune.Most recently, Dr. McKay was Vice President of Regulatory Affairs at Cell Genesys, where he was responsible for regulatory and quality assurance.Prior to Cell Genesys, Dr. McKay held senior management positions at Celtrix Pharmaceuticals, COR Therapeutics (now Millennium) and Berlex Biosciences.Earlier in his career, he worked at Triton Biosciences and Abbott Laboratories.Dr. McKay holds a Ph.D. in Biochemistry from the University of London and completed his post-doctoral training at the Medical College of Virginia.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory